These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37176153)

  • 1. Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives.
    Drapkina OM; Elkina AY; Sheptulina AF; Kiselev AR
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.
    Scapaticci S; D'Adamo E; Mohn A; Chiarelli F; Giannini C
    Front Endocrinol (Lausanne); 2021; 12():639548. PubMed ID: 33889132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density.
    Eshraghian A
    Minerva Endocrinol; 2017 Jun; 42(2):164-172. PubMed ID: 27973461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle.
    Poggiogalle E; Donini LM; Lenzi A; Chiesa C; Pacifico L
    World J Gastroenterol; 2017 Mar; 23(10):1747-1757. PubMed ID: 28348479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis.
    Filip R; Radzki RP; Bieńko M
    Clin Interv Aging; 2018; 13():1879-1891. PubMed ID: 30323574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Trends in Low Bone Density, Osteopenia and Osteoporosis in U.S. Adults With Non-Alcoholic Fatty Liver Disease, 2005-2014.
    Zhai T; Chen Q; Xu J; Jia X; Xia P
    Front Endocrinol (Lausanne); 2021; 12():825448. PubMed ID: 35126317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.
    Chiyanika C; Chan DFY; Hui SCN; So HK; Deng M; Yeung DKW; Nelson EAS; Chu WCW
    Pediatr Obes; 2020 Sep; 15(9):e12653. PubMed ID: 32351030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity.
    Barbieri E; Santoro N; Umano GR
    Front Endocrinol (Lausanne); 2023; 14():1062341. PubMed ID: 36733529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011.
    Ahn SH; Seo DH; Kim SH; Nam MS; Hong S
    Osteoporos Int; 2018 Jan; 29(1):181-190. PubMed ID: 29051986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity.
    Kim JY; Cho J; Yang HR
    J Korean Med Sci; 2018 Apr; 33(16):e122. PubMed ID: 29651819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
    Maruszczak K; Radzikowski K; Schütz S; Mangge H; Bergsten P; Forslund A; Manell H; Pixner T; Ahlström H; Kullberg J; Mörwald K; Weghuber D
    Front Endocrinol (Lausanne); 2022; 13():1004128. PubMed ID: 36133310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-alcoholic fatty liver disease and type 2 diabetes mellitus. I. Pathogenesis].
    Pár A; Wittmann I; Pár G
    Orv Hetil; 2022 May; 163(21):815-825. PubMed ID: 35598211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global view of the interplay between non-alcoholic fatty liver disease and diabetes.
    Stefan N; Cusi K
    Lancet Diabetes Endocrinol; 2022 Apr; 10(4):284-296. PubMed ID: 35183303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions.
    Cusi K
    Diabetologia; 2016 Jun; 59(6):1112-20. PubMed ID: 27101131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
    Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
    J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology.
    Memaj P; Jornayvaz FR
    Front Endocrinol (Lausanne); 2022; 13():1031633. PubMed ID: 36531463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.